Dr. Yoonchan Han

DDS | Oral and Maxillofacial Surgeon



  
  1111 Amsterdam Ave, New York
  New York, 10025-1716

  212-523-2952    Maps & Directions
Dr. Yoonchan Han is a New York, New York based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1111 Amsterdam Ave, New York. Patients can reach him at 212-523-2952.
Dr. Yoonchan Han deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Yoonchan Han speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Yoonchan Han
Specialization: Oral and Maxillofacial Surgeon
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:1111 Amsterdam Ave, New York,
New York, 10025-1716
Phone:212-523-2952
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 9537453741
Enrollment ID: I20160811000719
NPI Number: 1477782779
NPI Enumeration Date: 08 Jul, 2009
NPI Last Update On: 08 Jul, 2009

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 150 W 51st St Apt 918,
New York, New York
Zip: 10019-6840
Patients can reach Dr. Yoonchan Han at 1111 Amsterdam Ave, New York, New York or can call to book an appointment on 212-523-2952. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: